0001725160-23-000019.txt : 20230201 0001725160-23-000019.hdr.sgml : 20230201 20230201190840 ACCESSION NUMBER: 0001725160-23-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230201 FILED AS OF DATE: 20230201 DATE AS OF CHANGE: 20230201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gallagher Cam CENTRAL INDEX KEY: 0001557832 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39263 FILM NUMBER: 23578306 MAIL ADDRESS: STREET 1: 6042 CORNERSTONE CT. WEST STREET 2: SUITE B CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001725160 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823607803 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY, SUITE 1710 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (212) 433-3791 MAIL ADDRESS: STREET 1: 1359 BROADWAY, SUITE 1710 CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC DATE OF NAME CHANGE: 20200107 FORMER COMPANY: FORMER CONFORMED NAME: Zeno Pharma, LLC DATE OF NAME CHANGE: 20171212 4 1 wf-form4_167529650576789.xml FORM 4 X0306 4 2023-02-01 0 0001725160 Zentalis Pharmaceuticals, Inc. ZNTL 0001557832 Gallagher Cam C/O ZENTALIS PHARMACEUTICALS, INC. 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 1 1 0 0 President Common Stock 2023-02-01 4 A 0 161092 0 A 513103 D Stock Option (Right to Buy) 23.65 2023-02-01 4 A 0 233908 0 A 2033-01-31 Common Stock 233908.0 233908 D Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date. The option vests and becomes exercisable in 48 substantially equal monthly installments following the grant date. By: /s/ Melissa B. Epperly, attorney-in-fact for Cam S. Gallagher 2023-02-01